FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1424 May 2, 2002 Number 18 Next

PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Csernansky, J. G.

A Comparison of Risperidone and Haloperidol for the Prevention of Relapse in Patients with Schizophrenia . On page 19, the sentence that begins on line 1 of the right-hand column should have read, "In post hoc analyses, patients in both the risperidone and haloperidol groups had significant improvement from base line in symptoms after one week of double-blind treatment: the changes in total scores on the Positive and Negative Syndrome Scale were a decrease of 3.9 in the risperidone group (P<0.001) and a decrease of 1.4 in the haloperidol group (P=0.05; P=0.007 for the comparison between the groups)."

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.